Pill that could stop both hearing loss and tinnitus is now being tested

The first drug treatment for both conditions has been developed by scientists in the UK and acts on brain cells involved in the processing of sound.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

Publication date: Available online 17 August 2018Source: British Journal of Oral and Maxillofacial SurgeryAuthor(s): L.F.O. Maciel, F.S. Landim, B.C. VasconcelosAbstractIn a prospective, observational study between April and November 2017 we evaluated the correlation between temporomandibular disorder (TMD), and otological signs and other symptoms in a sample of 251 patients. First, a simplified anamnestic questionnaire was applied for the diagnosis of TMD and the following symptoms were recorded: otalgia, tinnitus, vertigo, pruritus of the ear, feeling of hearing loss, fullness in the ear, headache, pain in the eye, neck ...
Source: British Journal of Oral and Maxillofacial Surgery - Category: ENT & OMF Source Type: research
Sudden sensorineural hearing loss (SSNHL) is defined as a hearing loss of 30 dBHL or more in three consecutive frequency ranges within 72  hours as measured by pure tone audiometry [1,2]. The prevalence of SSNHL varies by region with an estimated worldwide prevalence of 5~20 cases/100,000 people [3]. Unilateral hearing loss, tinnitus, aural fullness, and vertigo are the most common symptoms of SSNHL [4]. SSNHL with these symptoms ca n have a devastating effect on quality of life and social functions, which suggests that a multidisciplinary (psychological, social, and medical) approach should be undertaken for these patients [5].
Source: Patient Education and Counseling - Category: International Medicine & Public Health Authors: Source Type: research
Repetitive Transcranial Magnetic Stimulation (rTMS) is a non-invasive neuromodulation treatment that involves the induction of electrical currents in a targeted region of the brain with the ability to impact various functional processes (Chervyakov  et al., 2015). rTMS has shown to provide clinical improvement among a variety of neurological and psychiatric disorders and has been FDA-approved for treatment resistant depression (TRD). rTMS continues to undergo trials for other treatment indications including post-traumatic stress disorder (PT SD), generalized anxiety disorder (GAD), bipolar depression, schizophren...
Source: Journal of Affective Disorders - Category: Neurology Authors: Tags: Research paper Source Type: research
DISCUSSION: A large percentage of workers exposed to noisy workplaces were vulnerable because hearing protection was neither required nor routinely used. Further work is required to assess whether this reflects gaps in health and safety legislation or its implementation. PMID: 30110508 [PubMed - in process]
Source: Health Reports - Category: International Medicine & Public Health Tags: Health Rep Source Type: research
CONCLUSIONS In this retrospective review, sectioning of the NI produced no major complications, such as permanent facial weakness or deafness, and was effective for patients when performed in addition to other procedures. After sectioning of the NI, patients experienced 4.8 years pain free and experienced 6.2 years of less pain than before surgery. Alone, sectioning of the NI was not effective. The pathophysiology of NIN is not entirely understood. It appears that neurovascular compression plays only a minor role in the syndrome and there is a high degree of overlap with TN. PMID: 30117769 [PubMed - as supplied by publisher]
Source: Journal of Neurosurgery - Category: Neurosurgery Authors: Tags: J Neurosurg Source Type: research
In a prospective, observational study between April and November 2017 we evaluated the correlation between temporomandibular disorder (TMD), and otological signs and other symptoms in a sample of 251 patients. First, a simplified anamnestic questionnaire was applied for the diagnosis of TMD and the following symptoms were recorded: otalgia, tinnitus, vertigo, pruritus of the ear, feeling of hearing loss, fullness in the ear, headache, pain in the eye, neck pain, back pain, and dizziness. Some degree of TMD was detected in 177 of the participants (70.5%).
Source: The British Journal of Oral and Maxillofacial Surgery - Category: ENT & OMF Authors: Source Type: research
Conclusion: Azithromycin short-term use was not associated with an increased risk of SNHL in comparison to amoxicillin ± clavulanate.
Source: Otology and Neurotology - Category: ENT & OMF Tags: Sens Orineural Hearing Loss and Tinnitus Source Type: research
Objectives: To investigate the risk of stroke in SSNHL patients. Study Design: A longitudinal follow-up cohort study. Setting: The Korean National Health Insurance Service-National Sample Cohort from 2002 to 2013. Patients: The 4,944 SSNHL participants were matched with 19,776 controls for age, sex, income, region of residence, hypertension, diabetes, and dyslipidemia. The SSNHL subjects were diagnosed (International Classification of Disease [ICD]-10: H91.2), underwent an audiometry examination, and were treated with steroids. The history of hemorrhagic stroke, ischemic stroke, hypertension, diabetes, dyslipide...
Source: Otology and Neurotology - Category: ENT & OMF Tags: Sens Orineural Hearing Loss and Tinnitus Source Type: research
Conclusion: Findings of this study further indicate that the left ear is more susceptible to noise exposure compared with the right ear.
Source: Otology and Neurotology - Category: ENT & OMF Tags: Sens Orineural Hearing Loss and Tinnitus Source Type: research
Conclusions: Patients with MEANTs can present with nonspecific symptomatology that overlaps with more commonly encountered middle ear lesions. MEANT exhibits a proclivity for recurrence according to T-stage and long-term clinical follow up is necessary, particularly for advanced stage tumors.
Source: Otology and Neurotology - Category: ENT & OMF Tags: Tumors of the Ear and Cranial Base Source Type: research
More News: Brain | Health | Neurology | Tinnitus